UBS Group »

Nkgen Biotech shares owned by UBS Group

Quarter-by-quarter ownership of Nkgen Biotech (NKGN) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Nkgen Biotech

Tip: Access up to 7 years of quarterly data

All positions including Nkgen Biotech held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nkgen Biotech by UBS Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $21k 11k 1.89

More positions owned by UBS Group

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Amazon Call Option (AMZN)
Ubs Group SHS Call Option (UBS)
JPMorgan Chase & Co. Call Option (JPM)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Meta Platforms Cl A Call Option (META)
Broadcom Call Option (AVGO)
Visa Com Cl A Call Option (V)
Alphabet Cap Stk Cl C Call Option (GOOG)
UnitedHealth Call Option (UNH)

View all positions for UBS Group

Top funds holding Nkgen Biotech

Meteora Capital
Polar Securities
University Of Chicago
Vanguard Group
Geode Capital Management
Susquehanna International
Sequoia Financial Advisors
Northern Trust
UBS Group
Towneley Capital Management, Inc / DE
Tower Research Capital
Federation des caisses Desjardins du Quebec
Wells Fargo & Company

View all funds holding Nkgen Biotech